[ad_1] In patients receiving nusinersen (Spinraza) for the treatment of SMA muscular disease (spinal muscular atrophy), symptoms of accumulation of cerebral fluid may develop. This is reported by the Medicines Evaluation Board …
Read More »Spinraza can lead to the head of the water – Actual
[ad_1] Patients receiving Nusinersen or Spinraza against SMA (Spinal Muscular Atrophy) muscular disease run the risk of accumulation of cerebrospinal fluid and therefore of a head of water, according to the Medicines …
Read More »